Education
About Us
Working with TipRanks
Follow Us
Aspira Women's Health Inc. (DE:CUL)
FRANKFURT:CUL
RESEARCH TOOLSreports
Total Valuation
Aspira Women's Health has a market cap or net worth of $2.04M. The enterprise value is ―.
Market Cap$2.04M
Enterprise Value―
Share Statistics
Aspira Women's Health has 29,784,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,784,560
Owned by Insiders12.78%
Owned by Institutions0.36%
Financial Efficiency
Aspira Women's Health’s return on equity (ROE) is 5.11 and return on invested capital (ROIC) is -6284.94%.
Return on Equity (ROE)5.11
Return on Assets (ROA)-2.38
Return on Invested Capital (ROIC)-6284.94%
Return on Capital Employed (ROCE)-707.74
Revenue Per Employee139.12K
Profits Per Employee-198.39K
Employee Count66
Asset Turnover1.67
Inventory Turnover11.36
Valuation Ratios
The current PE Ratio of Aspira Women's Health is -0.76. Aspira Women's Health’s PEG ratio is >-0.01.
PE Ratio-0.76
PS Ratio0.00
PB Ratio-0.57
Price to Fair Value-3.89
Price to FCF-0.11
Price to Operating Cash Flow-0.10
PEG Ratio>-0.01
Income Statement
In the last 12 months, Aspira Women's Health had revenue of 9.18M and earned -13.09M in profits. Earnings per share was -0.93.
Revenue9.18M
Gross Profit5.48M
Operating Income-16.28M
Pretax Income-13.09M
Net Income-13.09M
EBITDA-16.28M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -14.54M and capital expenditures -49.00K, giving a free cash flow of -14.59M billion.
Operating Cash Flow-14.54M
Free Cash Flow-14.59M
Free Cash Flow per Share-0.49
Dividends & Yields
Aspira Women's Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta18.81
52-Week Price Change-96.72%
50-Day Moving Average0.06
200-Day Moving Average0.53
Relative Strength Index (RSI)52.95
Average Volume (3m)500.00
Important Dates
Aspira Women's Health upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Aspira Women's Health as a current ratio of 0.76, with Debt / Equity ratio of -85.00%
Current Ratio0.76
Quick Ratio0.71
Debt to Market Cap0.28
Net Debt to EBITDA-0.06
Interest Coverage Ratio493.27
Taxes
In the past 12 months, Aspira Women's Health has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aspira Women's Health EV to EBITDA ratio is -0.67, with an EV/FCF ratio of -0.90.
EV to Sales1.19
EV to EBITDA-0.67
EV to Free Cash Flow-0.90
EV to Operating Cash Flow-0.90
Balance Sheet
Aspira Women's Health has $2.13M in cash and marketable securities with $2.14M in debt, giving a net cash position of $9.00K billion.
Cash & Marketable Securities$2.13M
Total Debt$2.14M
Net Cash$9.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.18
Margins
Gross margin is 58.12%, with operating margin of -177.28%, and net profit margin of -142.61%.
Gross Margin58.12%
Operating Margin-177.28%
Pretax Margin-142.61%
Net Profit Margin-142.61%
EBITDA Margin-177.28%
EBIT Margin-142.96%
Analyst Forecast
The average price target for Aspira Women's Health is $3.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$3.00
Price Target Upside4900.00% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―